Mickaël Guedj
Molecular Biology · 2007–2015
A researcher in the Science corpus: 3 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 38 citations into it
- Computational Theory and Mathematics — 8 citations into it
Whom Mickaël Guedj trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Mickaël Guedj's perspective
Ordered by how strongly the researchers Mickaël Guedj trusts endorse each paper. Same corpus, a different order for every researcher.
- The problem of synergism and antagonism of combined drugs.
- Multi-target therapeutics: when the whole is greater than the sum of the parts. (Drug Discovery Today)
- A scaling normalization method for differential expression analysis of RNA-seq data (Genome Biology)
- Mapping and quantifying mammalian transcriptomes by RNA-Seq (Nature Methods)
- Alternative Isoform Regulation in Human Tissue Transcriptomes (Nature)
- Understanding mechanisms underlying human gene expression variation with RNA sequencing (Nature)
- Controlling the false discovery rate: a practical and powerful approach to multiple testing
- Detecting differential usage of exons from RNA-seq data (Genome Research)
- Evaluation of statistical methods for normalization and differential expression in mRNA-Seq experiments (BMC Bioinformatics)
- RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome (BMC Bioinformatics)
Their papers
- A comprehensive evaluation of normalization methods for Illumina high-throughput RNA sequencing data analysis (2013) — 1,249 citations
- ChEBI: a database and ontology for chemical entities of biological interest (2007) — 1,192 citations
- Analysis of drug combinations: current methodological landscape (2015) — 1,024 citations